Map and ablate closed-loop cooled ablation catheter

Abstract
A system for performing mapping and ablation functions includes a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end. A tip section positioned at the distal end of the catheter body and includes a proximal portion and a distal portion. One or more electrode structures are formed on an exterior surface of the tip section. The one or more electrode structures each includes a mapping electrode at the distal portion of the tip section and a contact pad electrically coupled to the mapping electrode.
Description
TECHNICAL FIELD

The present disclosure generally relates to systems and methods for providing a therapy to a patient. More particularly, the present disclosure relates to a catheter for mapping and ablating tissue within the heart of the patient including mapping electrodes deposited on an exterior surface of the ablation electrode.


BACKGROUND

Atrial fibrillation is a condition in the heart causing irregular heartbeats due to generation of abnormal electrical signals. Various treatment regimens may be followed for treating arrhythmias, such as anti-arrhythmic medications and catheter ablation.


Catheter ablation is a non-surgical, minimally invasive procedure that involves killing an abnormal heart muscle responsible for heart racing. This produces a small area of dead heart muscle called a lesion. In order to make lesions and thereby treat arrhythmia, abnormal heart muscles are first targeted and mapped, such as through a mapping technique. A catheter generally includes one or more mapping electrodes configured to carry out mapping functions and a tip ablation electrode disposed at the tip portion configured to carry out the ablation function. Mapping typically involves percutaneously introducing the catheter having one or more mapping electrodes into the patient, passing the catheter through a blood vessel (e.g., the femoral vein or artery) and into an endocardial site (e.g., the atrium or ventricle of the heart) to map bioelectrical signals arising from the myocardial tissues and thereby, recognize the tissue that is the source of the arrhythmia. The tip of the ablation catheter including the tip ablation electrode can then deliver energy to the abnormal heart muscle, which disables it.


SUMMARY

Disclosed herein are embodiments of an ablation electrode including one or more mapping electrodes deposited on an exterior surface thereof at a distal end of a map and ablate catheter, as well map and ablate catheters including such deposited mapping electrodes.


In Example 1, a system for performing mapping and ablation functions includes a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end. The catheter further includes a tip section positioned at the distal end of the body such that the tip section includes a proximal portion and a distal portion. The system also includes one or more electrode structures on an exterior surface of the tip section such that the one or more electrode structures each includes a mapping electrode at the distal portion of the tip section and a contact pad electrically coupled to the mapping electrode.


In Example 2, the system according to Example 1, wherein the tip section includes an ablation electrode configured to deliver radio frequency (RF) energy for an RF ablation procedure, and wherein the one or more electrode structures are deposited on an exterior surface of the ablation electrode.


In Example 3, the system according to either Example 1 or Example 2, wherein the one or more electrode structures further includes an insulative base layer between each of the one or more electrode structures and the ablation electrode.


In Example 4, the system according to any of Examples 1-3, wherein the catheter includes at least one inner fluid lumen, wherein the ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode, and wherein the catheter system further includes a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.


In Example 5, the system according to any of Examples 1-4, wherein the ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode, wherein the exterior wall includes irrigation ports, and wherein the irrigation ports are in fluid communication with the open interior region to allow fluid to flow from the open interior region through the irrigation ports.


In Example 6, the system according to any of Examples 1-5, wherein the tip section includes a flexible balloon removably coupled to the distal end of the catheter.


In Example 7, the system according to any of Examples 1-6, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more electrode structures.


In Example 8, the system the system according to any of Examples 1-7, wherein each of the one or more electrode structures further includes a conductive trace between the contact pad and mapping electrode, and an insulative coating layer over the conductive trace.


In Example 9, the system according to Examples 8, wherein the conductive trace has an impedance of less than 100 ohms.


In Example 10, the system according to any of Examples 1-9, wherein the one or more electrode structures are formed via physical vapor deposition.


In Example 11, a system for performing mapping and ablation functions includes a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end and having at least one inner fluid lumen. The system further includes an ablation electrode coupled to the distal end of the catheter body, wherein the ablation electrode is configured to deliver radio frequency (RF) energy for an RF ablation procedure. The ablation electrode also includes an exterior wall that defines an open interior region within the ablation electrode. The system further includes a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass. The system further includes one or more insulative base layers on an exterior surface of the ablation electrode and one or more mapping electrodes each disposed on one of the one or more insulative base layers such that each mapping electrode can be proximate to a distal end of the ablation electrode.


In Example 12 the system according to Example 11, and further comprising one or more contact pads at a proximal end of the ablation electrode, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes.


In Example 13, the system according to either Example 11 or Example 12, wherein each contact pad is connected to one of the one or more mapping electrodes via a conductive trace.


In Example 14, the system according to Example 13, and further comprising an insulative coating layer over the conductive trace.


In Example 15, the system according to any of Examples 11-14, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more electrode structures.


In Example 16, the system according to any of Examples 11-15, wherein the mapping electrodes are formed via physical vapor deposition.


In Example 17, a system for performing mapping and ablation functions includes a radio frequency (RF) generator, a fluid reservoir and pump, a mapping signal processor, and a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end having at least one inner fluid lumen in fluid communication with the fluid reservoir and pump. The system further includes an ablation electrode coupled to the distal end of the catheter body, and operably connected to the RF generator. The ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode. The system further includes one or more insulative base layers on an exterior surface of the ablation electrode and one or more mapping electrodes operably connected to the mapping signal processor such that each mapping electrode can be disposed on one of the one or more insulative base layers. Each mapping electrode can be proximate to a distal end of the ablation electrode.


In Example 18 the system according to Example 17, and further comprising a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.


In Example 19 the system according to either Example 17 or Example 18, and further comprising one or more contact pads at a proximal end of the ablation electrode electrically connected to the mapping signal processor, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes via a conductive trace.


In Example 20, the system according to Example 19, and further comprising an insulative coating layer over each conductive trace.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic view of an embodiment of a system for performing mapping and ablation functions including a map and ablate catheter.



FIG. 2 is a schematic view of another embodiment of a system for performing mapping and ablation functions including a map and ablate catheter.



FIG. 3 is a side view of an embodiment of a tip section of a map and ablate catheter including an ablation electrode with one or more electrode structures deposited thereon.



FIG. 4 is a cross-sectional view of an embodiment of the tip section of the map and ablate catheter including deposited mapping electrode structures and a closed-loop cooling system.



FIG. 5 is a perspective view of an embodiment of an open irrigated tip section of a map and ablate catheter including deposited mapping electrode structures.



FIG. 6 is a perspective view of an embodiment of a non-irrigated tip section of a map and ablate catheter including deposited mapping electrode structures.



FIG. 7 is a perspective view of an embodiment of a mapping balloon including mapping electrodes deposited thereon.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 is a front view of a system 100 for performing mapping and ablation functions. As shown, the system 100 includes a catheter 102 sized and shaped for vascular access. The catheter 102 has a distal end 104 and a proximal end 106. In one aspect, the proximal end 106 of the catheter 102 includes a handle 108 having a proximal portion 110 and a distal portion 112, and is configured to be comfortably held by a practitioner during a treatment procedure involving ablation. The handle 108 can be composed of a durable and rigid material, such as medical grade plastic, and ergonomically molded to allow the physician to more easily manipulate the catheter 102. The handle 108 can incorporate a plurality of conduits, conductors, and wires to facilitate control of the catheter 102 and/or mating of the catheter 102 with a source of fluid, a source of ablative energy, a source of mapping, temperature display, sensors, and/or control software/hardware. The handle 108 further includes a connection port 113 through which ablative energy source and a mapping energy source can be operably coupled.


The catheter 102 can include an elongate body 114 having a proximal end 116 and a distal end 118. The body houses electrical conductors/cable assembly (e.g., wires) 120 for transmitting sensed signals and/or ablation energy. The elongate body 114 is preferably about 1.67 mm to 3 mm in diameter, and between 800 mm to 1500 mm in length. The elongate body 114 preferably has a circular cross-sectional geometry. However, other cross-sectional shapes, such as elliptical, rectangular, triangular, and various other shapes, can be provided. In some embodiments, the elongate body 114 can be preformed of an inert, resilient plastic material that retains its shape and does not soften significantly at body temperature; for example, Pebax®, polyethylene, or Hytrel®) (polyester). Alternatively, the elongate body 114 can be made of a variety of materials, including, but not limited to, metals and polymers. The elongate body 114 is preferably flexible so that it is capable of winding through a tortuous path that leads to a target site, i.e., an area within the heart. Alternatively, the elongate body 114 can be semi-rigid, i.e., by being made of a stiff material, or by being reinforced with a coating or coil, to limit the amount of flexing.


In some embodiments, the movement of the distal end 118 of the elongate body 114 (such as to wind through the tortuous path that leads to a target site) can be controlled by a control mechanism 122 included within the handle 120. The system 100 can include an articulating section of the elongate body 114 (e.g., near the distal end 118) that is controlled via the control mechanism 122. In some embodiments, the distal end 118 of the elongate body 114 can be deflected or bent. The articulation section of the body can facilitate insertion of the catheter 102 through a body lumen (e.g., vasculature) and/or placement of electrodes at a target tissue location. The articulation section can provide one or more degrees of freedom and permit up/down and/or left/right articulation. One skilled in the art will understand that the control mechanism 122 and the articulating section of the catheter 102 can include a variety of features associated with conventional articulating catheters.


The distal end 104 of the catheter 102 includes a tip section 124 positioned at the distal end 118 of the elongate body 114. The tip section 124 includes a proximal portion 134 and a distal portion 136. In some embodiments, the tip section 124 is formed from a conductive material. For example, in some embodiments the tip section 124 is comprised of a platinum-iridium alloy. In one exemplary embodiment, the platinum iridium top section 124 comprises an alloy with approximately 90% platinum and 10% iridium. This conductive material is used to conduct radio frequency (RF) energy used to form lesions during the ablation procedure. The ablation electrode 126 can have any suitable length, for example, in the range between 4 mm and 10 mm. The ablation electrode 126 can be composed of a solid, electrically conductive material, such as platinum, gold, or stainless steel. The ablation electrode 126 can be configured to deliver ablation energy to the myocardial tissues that are the source of arrhythmia, thereby destroying them or a portion thereof through heat. In an embodiment, the ablation electrode 126 can be electrically coupled to an RF generator, which will be discussed in further detail with regards to FIG. 2, so that ablation energy can be conveyed from the RF generator to the ablation electrode 126 to form localized lesions in the myocardial tissues. In an embodiment, an RF wire 128 can be electrically connected to the ablation electrode 126 using suitable means, such as soldering or welding. The RF wire 128 can pass through a lumen 144 extending through the elongate body 114 of the catheter 102, where it is further electrically coupled to the cable assembly 120 located within the handle 108 and to the RF generator exteriorly coupled to the catheter system 100.


The system 100 includes one or more electrode structures 142 on an exterior surface 130 of the tip section 124. The electrode structures 142 each include a mapping electrode 132 at the distal portion 136 of the tip section 124. The mapping electrode 132 is deposited on the tissue ablation electrode 126, and in particular, is deposited on an exterior surface 130 of the ablation electrode 126. This can allow the localized intracardial electrical activity to be measured in real time at the point of RF energy delivery from the ablation electrode 126 thereby allowing the physician to ascertain lesion formation by measuring the electrical activity of the tissue in contact with the tip ablation electrode 126 (e.g., the lack of electrical activity indicates ablated tissue, whereas the presence of electrical activity indicates live tissue). In some embodiments, the mapping electrodes 132 are deposited on the exterior surface 130 of the ablation electrode 126. In some embodiments, the one or more electrode structures 142 are deposited via physical vapor deposition (PVD). The physical vapor deposition may be used for the deposition of the electrodes formed of a metal. In alternative embodiments, other deposition techniques may be used for electrode deposition on the exterior surface 130 of the ablation electrode 126, such as sputtering.


In some embodiments, the electrode structures 142 each includes a contact pad that is electrically coupled to the mapping electrode 132. The contact pad can be configured to provide connection of the mapping electrode 132 with the cable assembly 120, thereby allowing the mapping electrode 132 to form electrical connection with the electrical circuitry of the catheter 102. In some embodiments, the mapping electrode 132 are electrically coupled to a mapping signal processor, which will be discussed in further detail with regards to FIG. 2, so that electrical events in myocardial tissue can be sensed for the generation of electrograms, monophasic action potentials (MAPs), isochronal electrical activity maps, and the like. In some embodiments, the signal wires 138 are respectively connected to the mapping electrodes 132 using suitable means such as soldering or welding. The signal wires 138 can pass through a lumen 144 extending through the elongate body 114 of the catheter 102, where it is electrically coupled to the cable assembly 120 located within the handle 108 and then to the mapping microprocessor.


The system 100 may also include one or more mapping ring electrodes 140. The mapping ring electrodes 140 can be configured to map the bioelectrical signals arising from the myocardial tissues and thereby recognize the tissues that are the source of arrhythmia. The mapping ring electrodes 140 can include a distal mapping ring electrode 140a, a medial mapping ring electrode 140b, and a proximal mapping ring electrode 140c. The mapping ring electrodes 140a, 140b, and 140c as well as the ablation electrode 126 are capable of forming a bipolar mapping electrode pairs. For example, the ablation electrode 126 and distal mapping ring electrode 140a can be configured as a first bipolar mapping electrode pair, the distal mapping ring electrode 140a and the medial mapping ring electrode 140b can be configured as a second bipolar mapping electrode pair, the medial mapping ring electrode 140b and the proximal mapping ring electrode 140c can be configured as a third bipolar mapping electrode pair, or any combination thereof. Like the mapping electrodes 132, the mapping ring electrodes 140a-140c are also electrically coupled to the mapping signal processor via the signal wires 138 to map electrical events in the myocardial tissues.



FIG. 2 illustrates an embodiment of the mapping and ablation system 100 including cooling, ablation, and mapping system components and a closed-irrigated catheter 102. The catheter 102 can be configured to be introduced through the vasculature of the patient, and into one of the chambers of the heart, where it can be used to map and ablate myocardial tissue. The system 100 also comprises a radio frequency (RF) generator 202, a fluid reservoir and pump 204, a mapping signal processor 206, coupled to the catheter 102 via a cable assembly or through connection port 113. In an embodiment, the radio frequency (RF) generator 202, and the mapping signal processor 206 can be connected to the catheter 102 through the RF wire 128 and the signal wires 138 of the cable assembly 120. In an embodiment, the fluid reservoir and pump 204 can be connected to the catheter 102 through the connection port 113.


Although the radio frequency (RF) generator 202, the fluid reservoir and the pump 204, and the mapping signal processor 206 are shown as discrete components, they can alternatively be incorporated into a single integrated device.


In some embodiments, the ablation electrode 126 coupled to the distal end 118 of the catheter body 114 can be operably connected to the RF generator 202. The RF generator 202 can be used to generate the energy for the ablation procedure. The RF generator 202 includes a source 208 for the RF energy and a controller 210 for controlling the timing and the level of the RF energy delivered through the tip 204. The illustrated system 100 also includes the fluid reservoir and pump 204 for pumping cooling fluid, such as a saline, through an inner fluid lumen of the catheter 102 (which will be discussed in greater detailed below) to the tip portion 124.


The mapping signal processor 206 can be operably coupled to the one or more electrodes similar to the mapping electrode 132. The mapping signal processor 206 can be configured to detect, process, and record electrical signals within the heart via the one or more electrodes of the catheter 102. Based on the electrical signals sensed by the one or more electrodes, the physician can identify the specific target tissue sites within the heart, and ensure that the arrhythmia causing substrates have been electrically isolated by the ablative treatment. Based on the detected electrical signals, the mapping signal processor 206 outputs electrocardiograms (ECGs) to a display (not shown), which can be analyzed by the physician to determine the existence and/or location of arrhythmia substrates within the heart and/or determine the location of the catheter 102 within the heart. In some embodiments, the mapping signal processor 206 can generate an isochronal map of the detected electrical activity and output the map to the display for analysis by the physician.



FIG. 3 is a side view of the tip section 124 including the ablation electrode 126 with the one or more electrode structures 142 deposited thereon. As shown in FIG. 3, the tip section 124 comprises the ablation electrode 126 configured to deliver radio frequency (RF) energy for the RF ablation procedure and the electrode structures 142. The electrode structures 142 each include the mapping electrode 132. The mapping electrodes 132 can be disposed on the tissue ablation electrode tip 304, and in particular, are deposited on the exterior surface 130 of the tissue ablation electrode tip 304. This allows the localized intracardial electrical activity to be measured in real time at the point of energy delivery from the ablation electrode 126. In addition, the mapping electrodes 132 do not sense far field electrical potentials that would normally be associated with bipolar measurements taken between the tissue ablation electrode 126 and the mapping ring electrodes 140a, 140b, 140c, due to their relatively small size and spacing between each of the electrode structures 142. Instead, the mapping electrodes 132 measure the highly localized electrical activity at the point of contact between the ablation electrode 126 and the endocardial tissue. Thus, the arrangement of the mapping electrodes 132 substantially enhances the mapping resolution of the catheter 102. The high resolution inherent in the arrangement of the mapping electrodes 132 allows a user to measure complex localized electrical activity more precisely, resulting in a powerful tool for diagnosing electrocardiogram (ECG) activity, for example, the high frequency potentials that are encountered around pulmonary veins or the fractioned ECGs associated with atrial fibrillation triggers. The arrangement of the mapping electrodes 132 can also allow generation of high density electrical activity maps such as electrical activity isochronal maps, which may be combined with anatomical maps, to create electro-anatomical maps. In addition, detection of tissue contact and tissue characterization, including lesion formation assessment, can be made more accurate due to the elimination or minimization of the detected far field electrical activity.


The mapping electrodes 132 can be small, independent diagnostic sensing electrodes deposited on the exterior surface 130 of the tip 304 of the RF ablation catheter 102. Each mapping electrode 132 can be composed of an electrically conductive material, such as platinum, gold, or stainless steel. In some embodiments, the mapping electrodes 132 are comprised of a silver/silver chloride to maximize the coupling between the mapping electrode 132 and blood, thereby optimizing signal fidelity. In some embodiments, the electrode structures 142 are formed via physical vapor deposition (PVD) or other suitable methods for deposing the electrodes onto the exterior surface 130.


The mapping electrodes 132 can be disposed on the ablation electrode 126 in any one of a variety of different patterns. In an example, as shown in FIG. 3, the mapping electrodes 132 are circumferentially disposed about the cylindrical-shaped region of the ablation electrode 126 at 120° intervals so that they face radially outward in different directions.


In some embodiments, each of the electrode structures 142 further includes a conductive trace 306 electrically coupled to the mapping electrode 132 and a contact pad 308 electrically connected to the conductive trace 306. In some embodiments, the contact pads 308 are disposed at a proximal portion of the tip 304. The contact pad 308 may be configured for electrical connection to a diagnostic device such as the mapping processor 206. In an embodiment, the conductive trace 306 can be offset either along the longitudinal or lateral axes of the catheter system 102 from the mapping electrode 132 so long as some portion of the conductive trace 306 remains in contact with the mapping electrode 132. Accordingly, the lateral and longitudinal cross-sections of both the mapping electrode 132 and the conductive trace 306 may vary similar to the variation in the depth or thickness of the conductive trace 306 and mapping electrode 132. In some embodiments, the conductive traces 306 have an impedance of less than 100 ohms.


In some embodiments, the catheter 102 includes a plurality of internal conductors each coupled to one of the contact pads 308. Thus, each of the mapping electrodes 132 can be electrically connected to other semiconductor devices, electronic components on the substrate, or components that are external to the catheter 102 such as the mapping processor.


In some embodiments, the electrodes 126, 132, and/or 140, the conductive trace 306, and contact pad 308 can be made from the same conductive materials. In some embodiments, the electrodes 126, 132, and/or 140, conductive trace 306, and contact pad 308 can be made of different conductive materials. For example, the contact pads 308 can be formed of a material such as gold (Au), platinum (Pt), palladium (Pd), ruthenium (Ru), rhodium (Rh), iridium (Ir), carbon (C), or other material that resists oxidation. The conductive traces 306 can be formed of any suitable conductive material, such as Au, Pt, or copper (Cu). The electrodes 126, 132, and/or 140, conductive trace 306, or contact pad 308 may be comprised of any suitable material including, for example, Pt, Au, Pd, Ru, Rh, Ir, silver (Ag), C, and their alloys or oxides. Conducting polymers, such as polypyrrole (PPy), polyaniline (PANi), polythiophene, poly(3,4-ethylenedioxythiophene) (PEDOT) or their derivatives may also be employed for the conductive elements of the catheter 102.


The electrode structures 142 may further include a multi-layer dielectric material 310 such that the multi-layer dielectric material 310 includes an insulative base layer 312 and/or an insulative coating layer 314. The multi-layer dielectric material 310 acts as a dielectric barrier between the ablation electrode 126 and the electrode structures 142 resisting the conductance of the RF energy from the ablation electrode 126 to the electrode structures 142. For this purpose, the system 100 includes the insulative base layers 312 between each of the one or more electrode structures 142 and the ablation electrode 126.


The insulative base layer 312 can be composed of a suitable electrically and thermally insulative material, such as a high temperature thermoset plastic with high dielectric properties, e.g., polyimide or plastics from the phenolic group, such as Bakelite® or Ultem® plastics. The electrically insulative material of the insulative base layer 312 makes the mapping electrode 132 electrically insulated from the ablation electrode 126, and thus, from each other, so that each of the mapping electrode 132 can provide independent mapping channels. The thermal insulative material of the insulative base layer 312 makes the mapping electrode 132 thermally insulated from the ablation electrode 126 to prevent saturation of the mapping channels that would otherwise cause interference from the heat generated during a radio frequency (RF) ablation procedure. The insulative base layer 310 can be formed on the exterior surface 130 of the ablation electrode 126 in a manner such that the mapping electrodes 132 can be each disposed on the insulative base layers 312 such that each of the mapping electrode 132 can be proximate to the ablation electrode 126. The insulative base layer 312 can be further coated with an insulative coating layer 314 such that the insulative coating layer 314 is provided over each of the conductive trace 306. The insulative coating layer 314 electrically isolates the conductive trace from surrounding structures.



FIG. 4 is a cross-sectional view of an embodiment of the tip section 124 of the map and ablate catheter including deposited electrode structures 142 and a closed-loop cooling system. The tip section 124 includes at least one inner fluid lumen 402 in fluid communication with the fluid reservoir and pump 204 (shown in FIG. 2). The ablation electrode 126 is configured to deliver RF energy for the RF ablation procedure. Generally, the tip section 124 on which the ablation electrode 126 is formed can be a hollow tip section 124 and can include an open interior region 410 defined by the exterior wall 130 of the tip section 124.


In some embodiments, the tip section 124 includes a thermal mass 404. The thermal mass 404 comprises a material having a high thermal conductivity. A temperature sensor 406 can be positioned at least partially within the thermal mass 404. In an embodiment, the thermal mass 404 substantially extends across the full width of the tip 124.


The tip section 124 further includes a cooling chamber 408 in fluid communication with the inner fluid lumens 402 of the elongate body 114 and positioned proximally to the thermal mass 404. The cooling chamber 408 substantially extends across an entire width of the tip 124 between the exterior walls similar to the exterior wall 130 of the tip 304. The cooling chamber 408 can be defined in the form of a cavity near the proximate end of the tip 124 that is bounded at its distal end 412 by the thermal mass 404 and is bounded at its proximal end 414 by a portion of the tip section 124 and/or by a portion of the elongate catheter body 114.


In the illustrated embodiment, the cooling chamber 408 is positioned proximal to at least a portion of the thermal mass 404 and/or adjacent to the proximal portion 110 of the tip section 124. As ablation energy moves through the tip section 124, areas of increased current density can develop and result in localized hotspots. The system 100, described herein, can reduce the effect of proximal hotspots through the use of the cooling chamber 408 in fluid communication with the fluid lumen 402 of the elongate body 114. As shown in FIG. 4, a first fluid lumen 402a and a second fluid lumen 402b are in fluid communication with the tip 124. The first lumen 402a can deliver a cooling fluid into, for example, the cooling chamber 408. At least a portion of the cooling fluid can then continue on a path as shown along the arrow directions, and as illustrated in FIG. 4. The tip 124 includes the second fluid lumen 402b for removing cooling fluid after the cooling fluid has absorbed heat within the cooling chamber 408. The second fluid lumen 402b can return the heated fluid through the catheter body 114 for egress from the system 100 to a proximal location, such as the fluid reservoir and pump 204 for cooling and/or recirculation. As a result, heat can be removed from the tip 124 through the path (as shown along the arrow directions) of the cooling fluid.


The tip section 124 includes one or more insulative base layers 416 on the exterior surface 130 of the ablation electrode 126 and one or more mapping electrodes similar to the mapping electrode 132 each disposed on one of insulative base layers 416. The electrically insulative material of the insulative base layer 416 makes the mapping electrode 132 electrically insulated from the ablation electrode 126 and from each other so that each of the mapping electrodes 132 can provide independent mapping channels.



FIGS. 5 and 6 are perspective views of an open irrigated tip and a non-irrigated tip, respectively, including the deposited one or more electrode structures 142. The catheter 102 as described in conjunction with the present invention can be a hybrid catheter 102 as it can be used simultaneously for both localized mapping and ablation functions. The catheter 102 can be configured to provide localized, high resolution ECG signals during ablation. The localized mapping enables the mapping to be precise. As shown in FIG. 5, the catheter 102 has an open-irrigated catheter design. The hollow tip section 124 on which the ablation electrode 126 are formed includes the open interior region 410 defined by the exterior wall 130 of the tip section 124. The exterior wall 130 further includes a plurality of irrigation ports 502. The irrigation ports 502 are in fluid communication with the open interior region 410 to allow fluid to flow from the open interior region 410 through the irrigation ports 502. A cooling fluid, such as a saline fluid, is delivered from a fluid reservoir and pump 202 (shown in FIG. 2) through the catheter 102 to the tip section 124, where the fluid exits through irrigation ports 502 to cool the ablation electrode 126 and surrounding tissue. Clinical benefits of such catheter 102 can include, but are not limited to, controlling the temperature and reducing coagulum formation on the tip section 124 of the catheter 102, preventing impedance rise of tissue in contact with the tip section 124, and maximizing potential energy transfer to the tissue. Additionally, the localized intra cardiac electrical activity can be recorded in real time or near-real time right at the point of energy delivery. However, the hybrid catheter design of the present disclosure can also have a non-irrigated design as shown in FIG. 6 n a non-irrigated tip catheter 102.



FIG. 7 illustrates a perspective view of a mapping balloon 702 for the purpose of mapping anatomical features and tissue. In an embodiment, the tip section 124 comprises the mapping balloon 702 which is removably coupled to the distal end 104 of the catheter 102. The balloon 702 can be mounted circumferentially on the distal end 118 of the elongate body 114 of the catheter 102. The balloon 702 can be elastic, and may be comprised of polyethylene cross-linked latex, although other biocompatible elastomer materials can be used. The balloon 702 at its surface can include an electrode diagnostic array feature. The electrode diagnostic array feature can include any or all of the electrodes such as one or more electrode structures 142, ablation electrode 126, and the mapping ring electrodes 140 for the purpose of ablating and mapping tissues. In some embodiments, the electrode array diagnostic array feature can include one or more electrode structures 142 each containing a mapping electrode 132 configured for picking up bioelectrical signals from the walls of blood vessels. The mapping electrodes 132 sense electrical potentials within the heart for the purpose of locating cardiac tissue containing abnormal electrical pathways. The balloon 702 can have a structure that can be easily adaptable to any one of the cardiac chambers and which can be used in the right or left ventricles of the heart without resorting to a ventriculotomy for mapping and/or ablating tissues of the heart. A proximal end 704 of the balloon 702 can be attached at the distal end 104 of the catheter 102 and can be constructed for insertion into a blood vessel. The balloon 702 can be mounted on the distal end 104 of the catheter 102 and a heating device (not shown) can also be mounted on the distal end 104 of the catheter 102 such that the heating device can be arranged for heating tissue in contact with the balloon 702 while the balloon 702 is inflated. In some embodiments, the catheter body 114 and the balloon 702 are sized and constructed to permit the distal end 118 of the catheter body 114 to be inserted into an atrium or ventricle of a heart while the balloon 702 is in a deflated configuration. The distal end 104 of the catheter 102 can be positioned within the atrium or ventricle and adjacent to a wall of the atrium or ventricle. The balloon 702 can then be inflated with fluid while the balloon 702 can be within the atrium or ventricle, for example to engage in direct contact with a wall of the atrium or ventricle. A tissue surrounding the balloon 702 can be heated through use of the heating device while the balloon 702 is inflated.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the above described features.

Claims
  • 1. A system comprising: a catheter sized and shaped for vascular access and including an elongate body extending between a proximal end and a distal end;a tip section including an ablation electrode configured to deliver radio frequency (RF) energy for an RF ablation procedure and positioned at the distal end of the body, the tip section including a proximal portion and a distal portion; andone or more electrode structures on an exterior surface of the ablation electrode, the one or more electrode structures each including a mapping electrode at the distal portion of the tip section and a contact pad electrically coupled to the mapping electrode.
  • 2. The system of claim 1, wherein the one or more electrode structures further includes an insulative base layer between each of the one or more electrode structures and the ablation electrode.
  • 3. The system of claim 1, wherein the catheter includes at least one inner fluid lumen, wherein the ablation electrode comprises an exterior wall that defines an open interior region within the ablation electrode, and wherein the system further comprises: a thermal mass within the open interior region; anda cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.
  • 4. The system of claim 1, wherein the ablation electrode comprises an exterior wall that defines an open interior region within the ablation electrode, wherein the exterior wall includes irrigation ports, and wherein the irrigation ports are in fluid communication with the open interior region to allow fluid to flow from the open interior region through the irrigation ports.
  • 5. The system of claim 1, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more electrode structures.
  • 6. The system of claim 1, wherein each of the one or more electrode structures further comprises: a conductive trace between the contact pad and mapping electrode; andan insulative coating layer over the conductive trace.
  • 7. The system of claim 6, wherein the conductive trace has an impedance of less than 100 ohms.
  • 8. The system of claim 1, wherein the one or more electrode structures are formed via physical vapor deposition.
  • 9. A system for performing mapping and ablation functions, the system comprising: a catheter sized and shaped for vascular access and including an elongate body extending between a proximal end and a distal end and having at least one inner fluid lumen;an ablation electrode coupled to the distal end of the catheter body, the ablation electrode configured to deliver radio frequency (RF) energy for an RF ablation procedure, the ablation electrode including an exterior wall that defines an open interior region within the ablation electrode;a thermal mass within the open interior region;a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass;one or more insulative base layers on an exterior surface of the ablation electrode; andone or more mapping electrodes each disposed on one of the one or more insulative base layers, each mapping electrode proximate a distal end of the ablation electrode.
  • 10. The system of claim 9, and further comprising: one or more contact pads at a proximal end of the ablation electrode, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes.
  • 11. The system of claim 10, wherein each contact pad is connected to one of the one or more mapping electrodes via a conductive trace.
  • 12. The system of claim 11, and further comprising an insulative coating layer over the conductive trace.
  • 13. The system of claim 9, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more mapping electrodes.
  • 14. The system of claim 9, wherein the mapping electrodes are formed via physical vapor deposition.
  • 15. A system for performing mapping and ablation functions, the system comprising: a radio frequency (RF) generator;a fluid reservoir and pump;a mapping signal processor;a catheter sized and shaped for vascular access and including an elongate body extending between a proximal end and a distal end and having at least one inner fluid lumen in fluid communication with the fluid reservoir and pump;an ablation electrode coupled to the distal end of the catheter body, the ablation electrode operably connected to the RF generator, the ablation electrode including an exterior wall that defines an open interior region within the ablation electrode;one or more insulative base layers on an exterior surface of the ablation electrode; andone or more mapping electrodes operably connected to the mapping signal processor, each mapping electrode disposed on one of the one or more insulative base layers, each mapping electrode proximate a distal end of the ablation electrode.
  • 16. The system of claim 15, and further comprising: a thermal mass within the open interior region; anda cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.
  • 17. The system of claim 15, and further comprising: one or more contact pads at a proximal end of the ablation electrode electrically connected to the mapping signal processor, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes via a conductive trace.
  • 18. The system of claim 17, and further comprising: an insulative coating layer over each conductive trace.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit of Provisional Application No. 61/702,626, filed Sep. 18, 2012, which is incorporated herein by reference in its entirety.

US Referenced Citations (167)
Number Name Date Kind
4732149 Sutter Mar 1988 A
4763660 Kroll et al. Aug 1988 A
5217460 Knoepfler Jun 1993 A
5238004 Sahatjian et al. Aug 1993 A
5254088 Lundquist et al. Oct 1993 A
5318589 Lichtman Jun 1994 A
5324284 Imran Jun 1994 A
5331966 Bennett et al. Jul 1994 A
5334193 Nardella Aug 1994 A
5341807 Nardella Aug 1994 A
5383874 Jackson et al. Jan 1995 A
5385146 Goldreyer Jan 1995 A
5391199 Ben-Haim Feb 1995 A
5398683 Edwards et al. Mar 1995 A
5423811 Imran et al. Jun 1995 A
5447529 Marchlinski et al. Sep 1995 A
5462521 Brucker et al. Oct 1995 A
5482054 Slater et al. Jan 1996 A
5500012 Brucker et al. Mar 1996 A
5573535 Viklund Nov 1996 A
5579764 Goldreyer Dec 1996 A
5582609 Swanson et al. Dec 1996 A
5647870 Kordis et al. Jul 1997 A
5718701 Shai et al. Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5800482 Pomeranz et al. Sep 1998 A
5820568 Willis Oct 1998 A
5830213 Panescu et al. Nov 1998 A
5836990 Li Nov 1998 A
5868735 Lafontaine Feb 1999 A
5871483 Jackson et al. Feb 1999 A
5913856 Chia et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
6027500 Buckles et al. Feb 2000 A
6050994 Sherman Apr 2000 A
6059778 Sherman May 2000 A
6064905 Webster, Jr. et al. May 2000 A
6070094 Swanson et al. May 2000 A
6083222 Klein et al. Jul 2000 A
6099524 Lipson et al. Aug 2000 A
6116027 Smith et al. Sep 2000 A
6120476 Fung et al. Sep 2000 A
6171305 Sherman Jan 2001 B1
6200314 Sherman Mar 2001 B1
6216027 Willis et al. Apr 2001 B1
6233491 Kordis et al. May 2001 B1
6270493 Lalonde et al. Aug 2001 B1
6290697 Tu et al. Sep 2001 B1
6400981 Govari Jun 2002 B1
6475213 Whayne et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6491710 Satake Dec 2002 B2
6508803 Horikawa et al. Jan 2003 B1
6517533 Swaminathan Feb 2003 B1
6517534 McGovern et al. Feb 2003 B1
6537271 Murray et al. Mar 2003 B1
6547788 Maguire et al. Apr 2003 B1
6575966 Lane et al. Jun 2003 B2
6579278 Bencini Jun 2003 B1
6602242 Fung et al. Aug 2003 B1
6640120 Swanson et al. Oct 2003 B1
6647281 Morency Nov 2003 B2
6656174 Hegde et al. Dec 2003 B1
6666862 Jain et al. Dec 2003 B2
6719756 Muntermann Apr 2004 B1
6735465 Panescu May 2004 B2
6796979 Lentz Sep 2004 B2
6796980 Hall Sep 2004 B2
6811550 Holland et al. Nov 2004 B2
6837884 Woloszko Jan 2005 B2
6845264 Skladnev et al. Jan 2005 B1
6917834 Koblish et al. Jul 2005 B2
6922579 Taimisto et al. Jul 2005 B2
6932811 Hooven et al. Aug 2005 B2
6950689 Willis et al. Sep 2005 B1
6952615 Satake Oct 2005 B2
7047068 Haissaguerre May 2006 B2
7097643 Cornelius et al. Aug 2006 B2
7112198 Satake Sep 2006 B2
7247155 Hoey et al. Jul 2007 B2
7347857 Anderson et al. Mar 2008 B2
7438714 Phan Oct 2008 B2
7519410 Taimisto et al. Apr 2009 B2
7569052 Phan et al. Aug 2009 B2
7736362 Eberl et al. Jun 2010 B2
7740629 Anderson et al. Jun 2010 B2
7799025 Wellman Sep 2010 B2
7819863 Eggers et al. Oct 2010 B2
8128617 Bencini et al. Mar 2012 B2
8414579 Kim et al. Apr 2013 B2
8579889 Bencini Nov 2013 B2
8657814 Werneth et al. Feb 2014 B2
8740900 Kim et al. Jun 2014 B2
8894643 Watson et al. Nov 2014 B2
9125668 Subramaniam et al. Sep 2015 B2
9211156 Kim et al. Dec 2015 B2
20010029371 Kordis Oct 2001 A1
20020087208 Koblish et al. Jul 2002 A1
20030088240 Saadat May 2003 A1
20040082860 Haissaguerre Apr 2004 A1
20040092806 Sagon et al. May 2004 A1
20040116793 Taimisto et al. Jun 2004 A1
20040215186 Cornelius et al. Oct 2004 A1
20050059862 Phan Mar 2005 A1
20050059962 Phan et al. Mar 2005 A1
20050059963 Phan et al. Mar 2005 A1
20050059965 Eberl et al. Mar 2005 A1
20050065506 Phan Mar 2005 A1
20050065508 Johnson et al. Mar 2005 A1
20050070894 McClurken Mar 2005 A1
20060089634 Anderson et al. Apr 2006 A1
20060161146 Cornelius et al. Jul 2006 A1
20060247607 Cornelius et al. Nov 2006 A1
20060253116 Avitall et al. Nov 2006 A1
20070049925 Phan et al. Mar 2007 A1
20070270794 Anderson et al. Nov 2007 A1
20080015568 Paul et al. Jan 2008 A1
20080058836 Moll et al. Mar 2008 A1
20080086073 McDaniel Apr 2008 A1
20080140065 Rioux et al. Jun 2008 A1
20080161705 Podmore et al. Jul 2008 A1
20080161795 Wang et al. Jul 2008 A1
20080195089 Thiagalingam et al. Aug 2008 A1
20080243214 Koblish Oct 2008 A1
20080281322 Sherman et al. Nov 2008 A1
20080300454 Goto Dec 2008 A1
20080312713 Wilfley et al. Dec 2008 A1
20090048591 Ibrahim et al. Feb 2009 A1
20090062790 Malchano et al. Mar 2009 A1
20090062795 Vakharia et al. Mar 2009 A1
20090093810 Subramaniam et al. Apr 2009 A1
20090093811 Koblish et al. Apr 2009 A1
20090131932 Vakharia et al. May 2009 A1
20090163904 Miller et al. Jun 2009 A1
20090182316 Bencini Jul 2009 A1
20090240247 Rioux et al. Sep 2009 A1
20090259274 Simon et al. Oct 2009 A1
20090287202 Ingle et al. Nov 2009 A1
20090299355 Bencini et al. Dec 2009 A1
20100010487 Phan et al. Jan 2010 A1
20100094274 Narayan et al. Apr 2010 A1
20100106155 Anderson et al. Apr 2010 A1
20100145221 Brunnett et al. Jun 2010 A1
20100152728 Park et al. Jun 2010 A1
20100168557 Deno et al. Jul 2010 A1
20100168831 Korivi et al. Jul 2010 A1
20100331658 Kim et al. Dec 2010 A1
20110028820 Lau et al. Feb 2011 A1
20110112569 Friedman et al. May 2011 A1
20110125143 Gross et al. May 2011 A1
20120101398 Ramanathan et al. Apr 2012 A1
20120330304 Vegesna et al. Dec 2012 A1
20130172715 Just et al. Jul 2013 A1
20130190747 Koblish et al. Jul 2013 A1
20130274582 Afonso et al. Oct 2013 A1
20140012251 Himmelstein et al. Jan 2014 A1
20140058375 Koblish Feb 2014 A1
20140073893 Bencini Mar 2014 A1
20140081112 Kim et al. Mar 2014 A1
20140107453 Maskara et al. Apr 2014 A1
20140107636 Bencini Apr 2014 A1
20150011995 Avitall et al. Jan 2015 A1
20150133914 Koblish May 2015 A1
20150265341 Koblish Sep 2015 A1
20150265348 Avitall et al. Sep 2015 A1
20150342672 Bencini et al. Dec 2015 A1
20150374436 Subramaniam et al. Dec 2015 A1
Foreign Referenced Citations (40)
Number Date Country
2682055 Oct 2008 CA
1455655 Nov 2003 CN
104640513 May 2015 CN
1343426 Sep 2003 EP
1343427 Sep 2003 EP
1502542 Feb 2005 EP
1547537 Jun 2005 EP
0985423 Apr 2006 EP
2136702 Jul 2015 EP
200083918 Mar 2000 JP
2009518150 May 2009 JP
2010522623 Jul 2010 JP
5336465 Nov 2013 JP
2014012174 Jan 2014 JP
20100021401 Feb 2010 KR
101490374 Feb 2015 KR
WO9221278 Dec 1992 WO
WO9413358 Jun 1994 WO
WO9725916 Jul 1997 WO
WO9725917 Jul 1997 WO
WO9736541 Oct 1997 WO
WO9858681 Dec 1998 WO
WO9927862 Jun 1999 WO
WO0029062 May 2000 WO
WO2007079278 Jul 2001 WO
WO0158372 Aug 2001 WO
WO0164145 Sep 2001 WO
WO0205868 Jan 2002 WO
WO0209599 Feb 2002 WO
WO0219934 Mar 2002 WO
WO0247569 Jun 2002 WO
WO02102234 Dec 2002 WO
WO03039338 May 2003 WO
2010054409 May 2010 WO
WO2010056771 May 2010 WO
2012161880 Nov 2012 WO
WO2008118992 Jan 2014 WO
2014072879 May 2014 WO
2015143061 Sep 2015 WO
2015183635 Dec 2015 WO
Non-Patent Literature Citations (27)
Entry
Goldberg, S. Nahum et al., “Variables Affecting Proper System Grounding for Radiofrequency Ablation in an Animal Model”, JVIR, vol. 11, No. 8, Sep. 2000, pp. 1069-1075.
International Search Report and Written Opinion issued in PCT/US2008/058324, dated Aug. 18, 2008, 11 pages.
International Search Report and Written Opinion issued in PCT/US2012/055309, mailed Nov. 19, 2012, 13 pages.
Machi MD, Junji, “Prevention of Dispersive Pad Skin Burns During RFA by a Simple Method”, Editorial Comment, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 372-373.
Neufeld, Gordon R. et al., “Electrical Impedance Properties of the Body and the Problem of Alternate-site Burns During Electrosurgery”, Medical Instrumentation, vol. 19, No. 2, Mar.-Apr. 1985, pp. 83-87.
Partial International Search Report issued in PCT/US2012/0551545, mailed Dec. 20, 2012, 7 pages.
Steinke, Karin et al., “Dispersive Pad Site burns With Modern Radiofrequency Ablation Equipment”, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 366-371.
International Preliminary Examination Report issued in PCT/US2013/060183, completed Mar. 24, 2015, 6 pages.
International Preliminary Report on Patentability issued in PCT/US2013/056211, completed Feb. 24, 2015, 5 pages.
International Preliminary Report on Patentability issued in PCT/US2013;060194, mailed Mar. 24, 2015, 6 pages.
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014, 10 pages.
International Search Report and Written Opinion issued in PCT/US2013/056211, mailed Jan. 20, 2014.
International Search Report and Written Opinion issued in PCT/US2013/060183, mailed Jan. 27, 2014, 10 pages.
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014.
Haverkamp, W., et. al. Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio-Physical Aspects and Experimental Findings. PACE, 12:187-195, Jan. 1989, Part II.
International Preliminary Report on Patentability issued in PCT/US2008/058324, mailed Sep. 29, 2009, 9 pages.
International Search Report and Written Opinion issued in PCT/US2013/021013, mailed Apr. 5, 2013, 14 pages.
International Search Report and Written Opinion issued in PCT/US2015/021300, mailed Jun. 9, 2015, 11 pages.
International Search Report and Written Opinion issued in PCT/US2015/055173, mailed Jan. 18, 2016, 11 pages.
International Search Report and Written Opinion issued in PCT/US2015/057242, mailed Jan. 15, 2016, 11 pages.
International Search Report and Written Opinion issued in PCTUS2015/031591, mailed Aug. 17, 2015, 11 pages.
Piorkowski, Christopher et al., “First in Human Validation of Impedance-Based Catheter Tip-to-Tissue Contact Assessment in the Left Atrium”, Journal of Cardiovascular Electrophysiology, vol. 20, No. 12, Dec. 1, 2009, pp. 1366-1373.
Pires, L. A., et. al. Temperature-guided Radiofrequency Catheter Ablation of Closed-Chest Ventricular Myocardium with a Novel Thermistor-Tipped Catheter. American Heart Journal, 127(6):1614-1618, Jun. 1994.
Price, Adam et al., “Novel Ablation Catheter Technology that Improves Mapping Resolution and Monitoring of Lesion Maturation”, The Journal of Innovations in Cardiac Rhythm Management, vol. 3, 2002, pp. 599-609.
Price, Adam et al., “PO3-39 Pin Electrodes Improve Resolution: Enhanced Monitoring of Radiofrequency Lesions in the Voltage and Frequency Domains”, Heart Rhythm 2010, 31st Annual Scientific Sessions, May 12-15 in Denver Colorado.
Ring, E. R., et. al. Catheter Ablation of the Ventricular Septum with Radiofrequency Energy. American Heart Journal, 117(6):1233-1240, Jun. 1989.
Zachary, J.M. et al., “PO4-86 Pin Electrodes Provide Enhanced Resolution Enabling Titration of Radiofrequency Duration to Lesion Maturation”, Heart Rhythm 2011, 32 Annual Scientific Sessions, May 4-7, San Francisco, CA.
Related Publications (1)
Number Date Country
20140081111 A1 Mar 2014 US
Provisional Applications (1)
Number Date Country
61702626 Sep 2012 US